Related Experiment Video
Updated: Apr 7, 2026

05:47
Isolation of Murine Lymph Node Stromal Cells
Published on: August 19, 2014
32.6K
Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.
P Bansal-Pakala1, A G Jember, M Croft
1Division of Immunochemistry, La Jolla Institute for Allergy and Immunology, San Diego, California, USA.
Nature Medicine
|August 2, 2001
Summary
Peripheral T-cell tolerance, a barrier in cancer, can be reversed. A single dose of an agonistic antibody targeting OX40 (CD134) restores CD4+ T-cell function and expansion, offering a therapeutic target.
Area of Science:
- Immunology
- Oncology
Background:
- Peripheral T-cell tolerance limits autoimmunity but hinders cancer treatment.
- Established tolerance involves suppressed T-cell accumulation and function.
- Reversing established T-cell tolerance remains a significant challenge.
Purpose of the Study:
- To investigate if established T-cell tolerance can be reversed.
- To identify potential therapeutic targets for breaking T-cell tolerance.
Main Methods:
- Utilized an agonistic antibody targeting OX40 (CD134).
- Administered a single dose of the antibody to break established tolerance.
- Assessed CD4+ T-cell compartment for expansion and functionality.
Main Results:
- A single dose of anti-OX40 antibody successfully broke established T-cell tolerance.
- OX40 signaling promoted T-cell expansion even after hypo-responsiveness was induced.
- Normal T-cell functionality was restored in the CD4+ compartment.
Conclusions:
- OX40 (CD134) possesses potent costimulatory capacity.
- Targeting OX40 is a promising strategy for therapeutic intervention in diseases involving T-cell tolerance.
- Reversing established tolerance is achievable, opening new avenues for cancer immunotherapy.
More Related Videos
Related Concept Videos
The Extrinsic Apoptotic Pathway
9.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.4K
T Cell Activation and Clonal Selection
17.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
17.5K
T Cell Types and Functions
3.3K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.3K

